Cargando…
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for highly potent monoclonal antibodies (mAbs) that are resistant against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VoCs). Here, we evaluate the potency of the previously des...
Autores principales: | Torres, Jonathan L., Ozorowski, Gabriel, Andreano, Emanuele, Liu, Hejun, Copps, Jeffrey, Piccini, Giulia, Donnici, Lorena, Conti, Matteo, Planchais, Cyril, Planas, Delphine, Manganaro, Noemi, Pantano, Elisa, Paciello, Ida, Pileri, Piero, Bruel, Timothée, Montomoli, Emanuele, Mouquet, Hugo, Schwartz, Olivier, Sala, Claudia, De Francesco, Raffaele, Wilson, Ian A., Rappuoli, Rino, Ward, Andrew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171815/ https://www.ncbi.nlm.nih.gov/pubmed/35549549 http://dx.doi.org/10.1073/pnas.2120976119 |
Ejemplares similares
-
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
por: Andreano, Emanuele, et al.
Publicado: (2022) -
Antibodies, epicenter of SARS-CoV-2 immunology
por: Pecetta, Simone, et al.
Publicado: (2021) -
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
por: Andreano, Emanuele, et al.
Publicado: (2021) -
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response
por: Andreano, Emanuele, et al.
Publicado: (2023) -
mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5
por: Andreano, Emanuele, et al.
Publicado: (2023)